Related Experiment Video

Updated: May 9, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1

Xin Zhou1, Min Wei, Wei Wang

  • 1Department of Orthopaedic Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, China.

Biochemical and Biophysical Research Communications
|July 23, 2013
PubMed

Insights

MicroRNA-340 (miR-340) acts as a tumor suppressor in osteosarcoma (OS). Its downregulation promotes OS progression and metastasis by increasing ROCK1 levels, suggesting miR-340 as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are crucial regulators in cancer development.
  • Osteosarcoma (OS) is a primary bone cancer with significant metastatic potential.
  • The specific role of miR-340 in OS progression remains largely unexplored.

Purpose of the Study:

  • To investigate the function of miR-340 in osteosarcoma (OS) progression and metastasis.
  • To identify the molecular mechanisms underlying miR-340's role in OS.
  • To evaluate miR-340 as a potential diagnostic and therapeutic target for OS.

Main Methods:

  • Quantitative real-time PCR to assess miR-340 expression in OS tissues and cell lines.
  • In vitro assays (proliferation, migration, invasion) to evaluate miR-340 function.
  • In vivo xenograft mouse model to assess tumor growth and metastasis.
  • Western blotting and luciferase reporter assays to identify and validate ROCK1 as a direct target of miR-340.

Main Results:

  • miR-340 was significantly downregulated in OS tumors and cell lines.
  • Overexpression of miR-340 suppressed OS cell proliferation, migration, and invasion in vitro.
  • miR-340 overexpression inhibited tumor growth and metastasis in vivo.
  • ROCK1 was identified as a direct target of miR-340, and its downregulation mediated the tumor-suppressive effects of miR-340.

Conclusions:

  • miR-340 functions as a tumor suppressor in osteosarcoma.
  • Downregulation of miR-340 contributes to OS progression and metastasis via ROCK1.
  • miR-340 represents a promising biomarker and therapeutic target for osteosarcoma.
Keywords:
OsteosarcomaROCK1miR-340

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...